Beth Boyer to lead a seminar on access to medicine at University of Nottingham
Date
30 November 2017
Each Access to Medicine Index is the product of a two-year process known as the ‘Index cycle’, which begins with a review of the Index methodology. The aim is to align the methodology with changes in access-to-medicine priorities and expectations as to how pharmaceutical companies can make their products available, accessible and affordable to people living in developing countries. The 2017 Methodology for the 2018 Access to Medicine Index was published in October 2017.